Margetuximab
HER2-IN-6
Zalutumumab
Ponezumab
Lys-Arg-Thr-Leu-Arg-Arg
Nelipepimut-S
DHFR-IN-4
Zanidatamab
Lumretuzumab
Tomuzotuximab
Intetumumab
Imgatuzumab
Seribantumab
Petosemtamab
Zenocutuzumab
Barecetamab
Anbenitamab
Timigutuzumab
Bafisontamab
Laprituximab